Merkel Cell Carcinoma (MCC)
Showing 1 - 25 of >10,000
Merkel Cell Carcinoma Trial in Milano, Siena, Verona (Pembrolizumab, Etoposide, Cisplatin or Carboplatin)
Not yet recruiting
- Merkel Cell Carcinoma
- Pembrolizumab, Etoposide, Cisplatin or Carboplatin
-
Milano, Italy
- +2 more
Oct 10, 2023
Merkel Cell Carcinoma Trial in Seattle (ITI-3000)
Recruiting
- Merkel Cell Carcinoma
-
Seattle, WashingtonUniversity of Washington/Seattle Cancer Care Alliance
Aug 1, 2022
Recurrent Merkel Cell Carcinoma, Stage III Merkel Cell Carcinoma AJCC v7, Stage IIIA Merkel Cell Carcinoma AJCC v7 Trial in
Completed
- Recurrent Merkel Cell Carcinoma
- +4 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Palo Alto, California
- +12 more
Mar 17, 2022
Merkel Cell Carcinoma Trial (Pembrolizumab, Lutetium Lu 177 dotatate)
Not yet recruiting
- Merkel Cell Carcinoma
- Pembrolizumab
- Lutetium Lu 177 dotatate
- (no location specified)
Oct 12, 2022
Merkel Cell Carcinoma Trial (biological, drug, radiation)
Withdrawn
- Merkel Cell Carcinoma
- Avelumab
- +14 more
- (no location specified)
Mar 17, 2021
Merkel Cell Carcinoma Trial in United States (Avelumab, N-803, haNK™)
Terminated
- Merkel Cell Carcinoma
- Avelumab
- +2 more
-
San Francisco, California
- +4 more
Jan 7, 2022
Merkel Cell Carcinoma Trial in United Kingdom (Radiotherapy, Surgery)
Active, not recruiting
- Merkel Cell Carcinoma
- Radiotherapy
- Surgery
-
Birmingham, United Kingdom
- +13 more
Feb 14, 2022
Stage IIIB Merkel Cell Carcinoma, Stage IV Merkel Cell Carcinoma Trial in Chicago, Pittsburgh, Seattle (aNK (NK-92))
Unknown status
- Stage IIIB Merkel Cell Carcinoma
- Stage IV Merkel Cell Carcinoma
- aNK (NK-92)
-
Chicago, Illinois
- +2 more
Aug 13, 2020
Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)
Not yet recruiting
- Merkel Cell Carcinoma
- Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
-
Wollstonecraft, New South Wales, AustraliaMelanoma Institute Australia
Nov 21, 2023
Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Locally Advanced Merkel Cell
Not yet recruiting
- Clinical Stage III Merkel Cell Carcinoma AJCC v8
- +5 more
- Avelumab
- +6 more
- (no location specified)
Jul 13, 2023
Merkel Cell Carcinoma, Neuroendocrine Carcinoma of the Skin, Trabecular Carcinoma of the Skin Trial in Tampa (Lenvatinib Oral
Recruiting
- Merkel Cell Carcinoma
- +2 more
- Lenvatinib Oral Product
- Pembrolizumab
-
Tampa, FloridaMoffitt Cancer Center
Dec 30, 2022
Merkel Cell Carcinoma Trial in Milan (Retifanlimab, Cisplatin, Etoposide)
Recruiting
- Merkel Cell Carcinoma
- Retifanlimab
- +2 more
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori di Milano
Jan 4, 2023
Merkel Cell Carcinoma, Skin Cancer Trial in Tampa, Columbus (Nivolumab, Ipilimumab, Stereotactic Body Radiation Therapy (SBRT))
Active, not recruiting
- Merkel Cell Carcinoma
- Skin Cancer
- Nivolumab
- +2 more
-
Tampa, Florida
- +1 more
Nov 11, 2022
Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell
Not yet recruiting
- Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
- +2 more
- Biopsy
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 28, 2023
Merkel Cell Carcinoma Trial in Philadelphia (Pembrolizumab)
Not yet recruiting
- Merkel Cell Carcinoma
-
Philadelphia, PennsylvaniaPenn Medicine
Aug 9, 2022
Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II Trial in Australia (Avelumab, Placebo)
Recruiting
- Merkel Cell Carcinoma
- +5 more
- Avelumab
- Placebo
-
Port Macquarie, New South Wales, Australia
- +17 more
Aug 30, 2022
Merkel Cell Carcinoma Clinical Trial Engagement Patterns
Not yet recruiting
- Merkel Cell Carcinoma
-
San Francisco, CaliforniaPower Life Sciences
Sep 8, 2023
Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV, Merkel Cell Carcinoma Trial (IFx-Hu2.0)
Available
- Cutaneous Melanoma, Stage III
- +3 more
- IFx-Hu2.0
- (no location specified)
Aug 5, 2022
Merkel Cell Carcinoma, Small Cell Lung Cancer Trial in United States (XmAb18087, XmAb18087 ± Pembrolizumab)
Completed
- Merkel Cell Carcinoma
- Small Cell Lung Cancer
- XmAb18087
- XmAb18087 ± Pembrolizumab
-
Duarte, California
- +6 more
Aug 8, 2022
Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)
Not yet recruiting
- Squamous Cell Carcinoma of the Skin
- +2 more
-
Marlborough, MassachusettsPhio Pharmaceuticals Corp.
Aug 25, 2023
Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)
Terminated
- Merkel Cell Polyomavirus Infection
- Stage IV Merkel Cell Carcinoma AJCC v7
- Avelumab
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 25, 2022
Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Orlando (Exercise Test)
Not yet recruiting
- Cutaneous Melanoma
- +2 more
- Exercise Test
-
Orlando, FloridaAdventHealth Translational Research Institute
Aug 18, 2023
Merkel Cell Carcinoma Trial in Australia (Carboplatin, Etoposide, Radiotherapy)
Completed
- Merkel Cell Carcinoma
- Carboplatin
- +2 more
-
Campbelltown, New South Wales, Australia
- +12 more
Nov 17, 2022